Skip to main content Skip to search Skip to main navigation
Flask High Quality Molecules
Truck Fast Delivery
Award Trusted by Researchers
Follow us: LinkedIn Contact Security
Latest Insights & Research

News & Discoveries

Stay updated with the latest breakthroughs in medicinal chemistry, drug discovery, and scientific innovation from Activate Scientific.

Featured Articles

LinkedIn

Heteroaromatic Sulfonyl Halides in Drug Discovery

Heteroaromatic sulfonyl chlorides and fluorides are versatile building blocks in medicinal chemistry. Their core reactivity is straightforward: sulfonyl chlorides react readily with amines to form sulfonamides, a widely used functional group in drug discovery. Introducing a heteroaromatic ring such as pyridine, thiazole or thiophene adds another layer of molecular design, influencing electronics, hydrogen-bonding and physicochemical properties compared with simple benzenesulfonyl analogues. A clinically relevant example is vonoprazan, marketed as VOQUEZNA, a potassium-competitive acid blocker approved by the FDA for erosive and non-erosive GERD, as well as in combination regimens for H. pylori infection. Reported synthetic routes use 3-pyridinesulfonyl chloride to sulfonylate a pyrrole intermediate, installing the pyridinesulfonyl group that forms a key part of vonoprazan's structure. This illustrates how heteroaromatic sulfonyl chlorides can serve as highly effective building blocks for assembling target-relevant functionality. Sulfonyl fluorides have attracted particular interest through sulfur\(VI\) fluoride exchange, or SuFEx. Their combination of useful stability and controlled reactivity makes them valuable both as synthetic handles and as covalent warheads. SuFEx chemistry has enabled covalent engagement of residues beyond the traditionally targeted cysteine, including tyrosine, lysine, histidine, serine and threonine. One striking example comes from fragment-based discovery of acetylcholinesterase inhibitors. Sulfonyl fluoride fragments with moderate activity were diversified through SuFEx into 102 sulfonamide analogues, with the optimised compound achieving around 70-fold higher potency and an IC₅₀ of 94 nM. Together, these examples highlight why heteroaromatic sulfonyl halides remain valuable tools in modern medicinal chemistry: they combine reliable synthetic reactivity with opportunities to tune molecular recognition, while sulfonyl fluorides additionally open the door to SuFEx-enabled library synthesis and covalent drug discovery. Explore our range of building blocks using the advanced search tools at https://lnkd.in/eVbfw6Ua 1.Synthesis and applications of heterocycle-containing sulfonyl fluorides for drug discovery: a critical review https://lnkd.in/gVhkdJxK 2. Sulfur-fluoride exchange \(SuFEx\)-enabled lead discovery of AChE inhibitors by fragment linking strategies https://lnkd.in/geMksVTf 3. Covalent drug discovery using sulfur\(VI\) fluoride exchange warheads https://lnkd.in/grQUMCSb

#ActivateScientific #MedicinalChemistry #DrugDiscovery
LinkedIn

Monofluorinated Piperidines in Drug Discovery

Piperidine is one of the most widely used saturated nitrogen heterocycles in medicinal chemistry, appearing across approved drugs and discovery programmes. Within this familiar scaffold, introducing a single fluorine atom provides another way to tune molecular properties, particularly at positions such as C3 and C4. Fluorination can reduce the basicity of the piperidine nitrogen while also influencing conformation, lipophilicity and pharmacokinetic behaviour. This can be valuable when excessive basicity, hERG liability or poor clearance becomes a limitation in lead optimisation. A striking example comes from the optimisation of indirect AMPK activators. Introducing a trans-3-fluoro substituent onto a piperidine lead increased the hERG IC₅₀ from 4.7 to 69 µM, consistent with reduced piperidine basicity. The modification also reduced rat plasma clearance from 150 to 19 mL/min/kg, while the fluorinated analogue showed 55% oral bioavailability in rats. The motif has also been explored in other areas of drug discovery. A 3-axial-fluoropiperidine was identified during the optimisation of T-type calcium-channel antagonists, where reducing piperidine basicity contributed to an improved selectivity profile. Fluorinated piperidines have also featured in MET inhibitor programmes, demonstrating their use within oncology-focused medicinal chemistry. Beyond conventional drug discovery, 3-fluoropiperidines have been investigated as building blocks for ¹⁸F-labelled PET radiotracers targeting NR2B-containing NMDA receptors. Although the reported tracers showed limitations in brain uptake, the work demonstrates the broader value of fluorinated piperidines in molecular imaging and radiochemistry. Taken together, these examples show how replacing a single C–H bond with C–F can provide a useful additional dimension for tuning piperidine-containing molecules without abandoning a highly established medicinal-chemistry scaffold. Explore our range of building blocks using the advanced search tools at https://lnkd.in/eVbfw6Ua To read more: 1\) Synthesis and Chemoinformatic Analysis of Fluorinated Piperidines as 3D Fragments for Fragment-Based Drug Discovery \(J. Org. Chem. 2024\) https://lnkd.in/djzF3Fvi 2\) Synthesis of Enantiopure Fluoropiperidines via Biocatalytic Desymmetrization and Flow Photochemical Decarboxylative Fluorination https://lnkd.in/d\_Y5gnGF

#ActivateScientific #MedicinalChemistry #DrugDiscovery
LinkedIn Follow Activate Scientific Arrow